HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Khalili Selected Research

Tumor Viral Antigens (Large T Antigen)

4/2007Inhibition of IGF-I receptor in anchorage-independence attenuates GSK-3beta constitutive phosphorylation and compromises growth and survival of medulloblastoma cell lines.
8/2006Role of the interaction between large T antigen and Rb family members in the oncogenicity of JC virus.
8/2006Interaction of retinoblastoma protein family members with large T-antigen of primate polyomaviruses.
3/2002Expression of JC virus T-antigen in a patient with MS and glioblastoma multiforme.
10/2001Concomitant progressive multifocal leucoencephalopathy and primary central nervous system lymphoma expressing JC virus oncogenic protein, large T antigen.
10/2001Expression of a human polyomavirus oncoprotein and tumour suppressor proteins in medulloblastomas.
8/2001Involvement of Wnt signaling pathway in murine medulloblastoma induced by human neurotropic JC virus.
5/2001Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system.
1/2001Human neurotropic JC virus and its association with brain tumors.
12/2000Reactivation of human neurotropic JC virus expressing oncogenic protein in a recurrent glioblastoma multiforme.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Khalili Research Topics

Disease

15Neoplasms (Cancer)
01/2008 - 05/2000
7Glioblastoma (Glioblastoma Multiforme)
03/2002 - 08/2000
6Infections
08/2006 - 10/2000
5Medulloblastoma
04/2007 - 08/2000
5Acquired Immunodeficiency Syndrome (AIDS)
09/2003 - 05/2000
4Carcinogenesis
08/2006 - 10/2000
4Retinoblastoma (Glioblastoma, Retinal)
08/2006 - 05/2000
4Brain Neoplasms (Brain Tumor)
10/2001 - 05/2000
3Progressive Multifocal Leukoencephalopathy
12/2011 - 06/2000
2Multiple Sclerosis
12/2011 - 03/2007
2Disease Progression
09/2003 - 02/2001
2Glioma (Gliomas)
05/2001 - 08/2000
2Virus Diseases (Viral Diseases)
02/2001 - 05/2000
1Rheumatoid Arthritis
12/2011
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2011
1Psoriasis (Pustulosis Palmaris et Plantaris)
12/2011
1Neuroblastoma
08/2008
1Chromosome Aberrations (Chromosome Abnormalities)
01/2008
1Hypersensitivity (Allergy)
04/2007
1Cerebellar Neoplasms
04/2007
1Nervous System Diseases (Neurological Disorders)
12/2001
1AIDS Dementia Complex
12/2001
1Lymphoma (Lymphomas)
10/2001
1Astrocytoma (Pilocytic Astrocytoma)
05/2001
1HIV Infections (HIV Infection)
02/2001
1Pituitary Neoplasms (Pituitary Adenoma)
10/2000
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
05/2000
1Demyelinating Diseases (Demyelinating Disease)
05/2000

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
08/2006 - 05/2000
14Tumor Viral Antigens (Large T Antigen)IBA
04/2007 - 05/2000
5Oncogene Proteins (Oncogene Protein)IBA
04/2007 - 05/2000
3DNA (Deoxyribonucleic Acid)IBA
08/2006 - 05/2001
3AntibodiesIBA
10/2001 - 02/2001
3NF-kappa B (NF-kB)IBA
05/2001 - 08/2000
2Natalizumab (Tysabri)FDA Link
12/2011 - 03/2007
2Viral ProteinsIBA
09/2004 - 08/2001
2CytokinesIBA
09/2003 - 02/2001
2Capsid Proteins (Capsid Protein)IBA
03/2002 - 06/2000
2AntigensIBA
12/2001 - 08/2000
2Transcription Factors (Transcription Factor)IBA
05/2001 - 12/2000
1efalizumab (Raptiva)FDA Link
12/2011
1Rituximab (Mabthera)FDA Link
12/2011
1Monoclonal AntibodiesIBA
12/2011
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
08/2008
1Therapeutic UsesIBA
01/2008
1Antineoplastic Agents (Antineoplastics)IBA
01/2008
1Cisplatin (Platino)FDA LinkGeneric
01/2008
1Glycogen Synthase Kinase 3 betaIBA
04/2007
1SuspensionsIBA
04/2007
1Insulin-Like Growth Factor I (IGF-1)IBA
04/2007
1NVP-AEW541IBA
04/2007
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
04/2007
1Interferon beta-1aFDA Link
03/2007
1Interleukin-2 (IL2)IBA
09/2003
1Interleukin-4 (Interleukin 4)IBA
09/2003
1Interleukin-6 (Interleukin 6)IBA
09/2003
1Interleukin-10 (Interleukin 10)IBA
09/2003
1Interleukin-13IBA
09/2003
1Viral DNAIBA
03/2002
1Lipopolysaccharide ReceptorsIBA
12/2001
1Biomarkers (Surrogate Marker)IBA
12/2001
1Ribonucleases (Ribonuclease)IBA
10/2001
1Flurbiprofen (Froben)FDA LinkGeneric
10/2001
1Pharmaceutical PreparationsIBA
10/2001
1Cell Cycle ProteinsIBA
10/2001
1beta CateninIBA
08/2001
1Lymphoid Enhancer-Binding Factor 1IBA
08/2001
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
05/2001
1TubulinIBA
05/2001
1Messenger RNA (mRNA)IBA
05/2001
1Biological ProductsIBA
03/2001
1AutoantibodiesIBA
02/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2001
1VaccinesIBA
02/2001
1Antiviral Agents (Antivirals)IBA
02/2001
1Tumor Suppressor Protein p53IBA
10/2000
1IntegrinsIBA
08/2000
1Tetracycline (Achromycin)FDA LinkGeneric
05/2000

Therapy/Procedure

2Therapeutics
12/2011 - 03/2007
2Drug Therapy (Chemotherapy)
03/2001 - 05/2000
1Transplantation
08/2000